SLXN Stock: Silexion Therapeutics Ltd. Stock Price, Analysis & Insights
Get live slxn stock price $4.07, comprehensive Silexion Therapeutics Ltd. stock analysis, charts, news, and expert forecast. Real-time slxn stock data and investment insights.
Company Overview
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Company Information
- CEO
- Ilan Hadar
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 11
Contact Information
- Website
- https://silexion.com
- Address
- The Goldyne Savad Institute of Gene Therapy
- Country
- IL
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 2.28M market capitalization
- Trading Volume: 1.11M shares traded today
- Price Range: 52-week range of $3.10 - $63.45
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for Silexion Therapeutics Ltd.
Silexion Therapeutics Ltd. (SLXN) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 2.28M, the company represents a significant player in its market. The stock is currently trading at $4.07 with a negativedaily change of 17.44%.
The company's 11 employee base and presence on the NASDAQ Global Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.13, beta of 0.04, and 52-week price range from $3.10 to $63.45when evaluating investment opportunities.
Why Invest in Silexion Therapeutics Ltd.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under Ilan Hadar
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.